Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Eczema, a chronic inflammatory skin condition, significantly impacts patients’ quality of life through persistent itching and irritation. The market is being driven by growing awareness, increasing diagnosis rates, and the expanding availability of advanced therapies. The introduction of biologics and targeted treatments